Integrated Solutions at Piramal Pharma Solutions
Piramal Pharma Solutions offers end-to-end integrated services across the spectrum of the entire drug life cycle including discovery, development, and commercial manufacturing of drug substances and drug products from our global network of 13 development and manufacturing facilities located in North America (4), Europe (2) and Asia (7).
In the area of Oncology, we have established global leadership as a preferred integrated partner. As one of the world leaders in the ADC segment, PPS provides integrated ADC manufacturing solutions from development through clinical and commercial manufacturing from Grangemouth, UK and ADC fill/finish from Lexington, KY, US. The cytotoxic payload is supplied from our Riverview facility located in Michigan, US. Our Riverview facility is forwarded integrated with our recently acquired Sellersville facility and Lexington for developing potent formulations. All our drug substance and drug product sites are well integrated with each other.
The integrated approach reduces delivery timelines and improves time to market for our customers, allowing customers to monetize time savings and reap the value of early and on-time product launches. Our Integrated program managers serve as the single point of contact for customers whose projects run across multiple sites.
Piramal’s strong integrated network of drug substance and drug product capabilities has resulted in over 100 successful integrated projects. Our ultimate objective is to assist our pharma and biotech customers in their quest to improve the lives of patients.